Health anxiety and depression in patients with fibromyalgia syndrome.

Autor:	Uçar M; Department of Physical Medicine and Rehabilitation, Bozok University Medical School, Yozgat, Turkey drmehmetucar@msn.com., Sarp Ü; Department of Physical Medicine and Rehabilitation, Yozgat State Hospital, Yozgat, Turkey., Karaaslan Ö; Department of Psychiatry, Yozgat State Hospital, Yozgat, Turkey., Gül AI; Department of Psychiatry, Bozok University Medical School, Yozgat, Turkey., Tanik N; Department of Neurology, Bozok University Medical School, Yozgat, Turkey., Arik HO; Department of Orthopaedics and Traumatology, Yozgat State Hospital, Yozgat, Turkey.
Jazyk:	angličtina
Zdroj:	The Journal of international medical research [J Int Med Res] 2015 Oct; Vol. 43 (5), pp. 679-85. Date of Electronic Publication: 2015 Aug 06.
DOI:	10.1177/0300060515587578
Abstrakt:	Objectives: To investigate health anxiety and depressive symptoms in patients with fibromyalgia syndrome (FMS). Methods: Patients with FMS and healthy control subjects were recruited. All participants completed the Health Anxiety Inventory Short Form (HAI-SF) and Beck Depression Inventory (BDI). Pain was assessed in patients with FMS using the Fibromyalgia Impact Questionnaire (FIQ) and Visual Analogue Scale (VAS). Results: This study involved 95 patients with FMS (15 male) and 95 healthy controls (17 male). Mean ± SD HAI-SF and BDI scores were significantly higher in patients with FMS = than in controls=. HAI-SF scores were 23.50 ± 10.78 and 9.38 ± 4.24 respectively; BDI scores were 18.64 ± 10.11 and 6.21 ± 4.05 respectively. There were highly significant correlations between FIQ and HAI-SF, FIQ and BDI, and HAI-SF and BDI. Conclusions: Patients with FMS had significantly higher HAI-SF and BDI scores than healthy controls. Psychiatric support is essential for patients with FMS. Treatment should include biological, psychological and social approaches. (© The Author(s) 2015.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu